Melbourne's ophthalmology community — anchored by the Royal Victorian Eye and Ear Hospital and the Centre for Eye Research Australia at the University of Melbourne — manages one of Australia's largest glaucoma patient populations. Lumigan (Bimatoprost 0.01%) provides Melbourne glaucoma patients with the same proven intraocular pressure reduction as brand Lumigan at significantly reduced cost, supporting the lifelong adherence essential to preventing glaucomatous vision loss.
Glaucoma affects approximately 300,000 Australians with many undiagnosed, and Melbourne's ageing population creates growing demand for affordable, sustainable glaucoma therapy. The cost of lifelong eye drops is a genuine adherence barrier for many Melbourne patients — affordable Lumigan supply from Unnati Pharmax directly supports the consistent daily use that protects long-term vision.
Visit medshopy.com or WhatsApp +91 82650 41513 for Melbourne supply.
Glaucoma affects approximately 300,000 Australians with many undiagnosed, and Melbourne's ageing population creates growing demand for affordable, sustainable glaucoma therapy. The cost of lifelong eye drops is a genuine adherence barrier for many Melbourne patients — affordable Lumigan supply from Unnati Pharmax directly supports the consistent daily use that protects long-term vision.
Visit medshopy.com or WhatsApp +91 82650 41513 for Melbourne supply.